Corbus Pharmaceuticals Holdings, Inc. · NASDAQ:CRBP
Saxena Nishant C bought 13,500 Corbus Pharmaceuticals Holdings, Inc. shares (Form 4)
Traded Jun 2 to Jun 3, 2026 · Filed Jun 3, 2026
From Jun 2 to Jun 3, 2026, Saxena Nishant C (Chief Business Officer) bought 13,500 Corbus Pharmaceuticals Holdings, Inc. shares at an average US$7.50 for US$101K, leaving 75,300 shares. Filed Jun 3, 2026 (Form 4).
- Bought
- 13,500 shares
- Price
- US$7.50 average (US$7.33 to US$7.58)
- Value
- US$101K
- Holding after
- 75,300 shares
- Trading plan
- No
- Role
- Chief Business Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | Common Stock, par value $0.0001 per share | Buy | 4,500 | US$7.33 | 66,300 | Direct |
| Jun 3, 2026 | Common Stock, par value $0.0001 per share | Buy | 9,000 | US$7.58 | 75,300 | Direct |
Source
Related
- Corbus Pharmaceuticals Holdings, Inc.
- Saxena Nishant C
- Corbus Pharmaceuticals Holdings, Inc. shareholders
- Form 4 · Saxena Nishant C · Aug 12, 2026
- Form 4 · Saxena Nishant C · May 22, 2026
- Schedule 13G · Ra Capital Management, L.P. · Sep 30, 2026
- Form 4 · Ben Yong · Sep 15, 2026
- Form 4 · Nicacio Leonardo Viana · Aug 17, 2026
- Schedule 13G/A · Citadel Advisors LLC · Aug 14, 2026
- Form 4 · Cohen Yuval · Aug 10, 2026